NO136841C - Analogifremgangsm}te for fremstilling av terapeutisk aktive fenylimidazolidinoner - Google Patents

Analogifremgangsm}te for fremstilling av terapeutisk aktive fenylimidazolidinoner

Info

Publication number
NO136841C
NO136841C NO2007/72A NO200772A NO136841C NO 136841 C NO136841 C NO 136841C NO 2007/72 A NO2007/72 A NO 2007/72A NO 200772 A NO200772 A NO 200772A NO 136841 C NO136841 C NO 136841C
Authority
NO
Norway
Prior art keywords
phenylimidazolidinones
preparation
therapeutically active
analogical procedure
analogical
Prior art date
Application number
NO2007/72A
Other languages
English (en)
Other versions
NO136841B (no
Inventor
Anton Mentrup
Ernst-Otto Renth
Kurt Schromm
Peter Danneberg
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of NO136841B publication Critical patent/NO136841B/no
Publication of NO136841C publication Critical patent/NO136841C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO2007/72A 1971-06-07 1972-06-06 Analogifremgangsm}te for fremstilling av terapeutisk aktive fenylimidazolidinoner NO136841C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT492071A AT311956B (de) 1971-06-07 1971-06-07 Verfahren zur Herstellung neuer Phenylimidazolidinonderivate und ihrer Salze

Publications (2)

Publication Number Publication Date
NO136841B NO136841B (no) 1977-08-08
NO136841C true NO136841C (no) 1977-11-16

Family

ID=3569889

Family Applications (1)

Application Number Title Priority Date Filing Date
NO2007/72A NO136841C (no) 1971-06-07 1972-06-06 Analogifremgangsm}te for fremstilling av terapeutisk aktive fenylimidazolidinoner

Country Status (20)

Country Link
AR (7) AR200112A1 (no)
AT (1) AT311956B (no)
AU (1) AU473287B2 (no)
BE (1) BE784475A (no)
BG (1) BG22822A3 (no)
CA (1) CA1011336A (no)
CH (7) CH590269A5 (no)
DD (1) DD101403A5 (no)
DE (1) DE2223751A1 (no)
ES (1) ES403542A1 (no)
FR (1) FR2140492B1 (no)
GB (1) GB1391491A (no)
HU (1) HU165493B (no)
IE (1) IE37812B1 (no)
IL (1) IL39620A (no)
NL (1) NL7207701A (no)
NO (1) NO136841C (no)
SE (1) SE392902B (no)
SU (8) SU453839A3 (no)
ZA (1) ZA723840B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19822678A1 (de) * 1998-05-20 1999-11-25 Bayer Ag Substituierte 1,3-Diaza-2-(thi)oxo-cycloalkane
CA2568609A1 (en) * 2003-05-28 2004-12-09 Imotep Inc. Haloethyl urea compounds and their use to attenuate, inhibit or prevent non-cancerous pathogenic cellular proliferation and diseases associated therewith
WO2004106291A1 (en) * 2003-05-28 2004-12-09 Imotep Inc. Haloethyl urea compounds and the use thereof to attenuate, inhibit or prevent cancer cell migration
RU2497810C1 (ru) * 2012-06-28 2013-11-10 Общество с ограниченной ответственностью "Объединенный центр исследований и разработок" Способ получения n,n-диарилзамещенных 2-трихлорометилимидазолидинов

Also Published As

Publication number Publication date
FR2140492A1 (no) 1973-01-19
BG22822A3 (no) 1977-04-20
AR202904A1 (es) 1975-07-31
IE37812L (en) 1972-12-07
IL39620A (en) 1977-02-28
CH589645A5 (no) 1977-07-15
SU499806A3 (ru) 1976-01-15
CH589646A5 (no) 1977-07-15
DD101403A5 (de) 1973-11-05
CH590269A5 (no) 1977-07-29
DE2223751A1 (de) 1972-12-28
SU503516A3 (ru) 1976-02-15
FR2140492B1 (no) 1976-03-05
CA1011336A (en) 1977-05-31
SU509228A3 (ru) 1976-03-30
ZA723840B (en) 1974-02-27
SU453839A3 (ru) 1974-12-15
SU505358A3 (ru) 1976-02-28
NL7207701A (no) 1972-12-11
AR203017A1 (es) 1975-08-08
AR207109A1 (es) 1976-09-15
ES403542A1 (es) 1975-05-01
CH573425A5 (no) 1976-03-15
AR200139A1 (es) 1974-10-24
GB1391491A (en) 1975-04-23
BE784475A (fr) 1972-12-06
HU165493B (no) 1974-09-28
AT311956B (de) 1973-12-10
AR200112A1 (es) 1974-10-24
SU493067A3 (ru) 1975-11-25
SE392902B (sv) 1977-04-25
AR202903A1 (es) 1975-07-31
AU473287B2 (en) 1973-12-13
SU498907A3 (ru) 1976-01-05
SU492085A3 (ru) 1975-11-15
AU4312972A (en) 1973-12-13
CH591475A5 (no) 1977-09-15
AR205522A1 (es) 1976-05-14
NO136841B (no) 1977-08-08
IL39620A0 (en) 1972-08-30
IE37812B1 (en) 1977-10-26
CH589644A5 (no) 1977-07-15
CH583729A5 (no) 1977-01-14

Similar Documents

Publication Publication Date Title
NO136837C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive pleuromutiliner
NO138805C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive triazolforbindelser
NO137321C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive 3-okso-17alfa-acyloksyandrost-4-en-17beta-karboksylsyreestere
NO137234C (no) Analogifremgangsm}te ved fremstilling av antelmintisk og mikrobicid virksomme forbindelser
NO137694C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner
NO136045C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazinoner.
NO138999C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner
NO773495L (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive fenylalkylaminer
NO136251C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazin-derivater.
SE402460B (sv) Analogiforfarande for framstellning av alkaloidestrar av eburnamintyp
NO137858C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
NO140596C (no) Analogifremgangsmaate for fremstilling av en terapeutisk aktive hydroksyalkylxantiner
NO137151C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive ortiotropin-peptider
NO136795C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive indoliner
NO136926C (no) Analogifremgangsm}te til fremstilling av terapeutisk aktive papaverinanaloger
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
SE399069B (sv) Analogiforfarande for framstellning av triazolo-pyridino-isokinolin-derivat
NO136574C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive pyrimidinderivater.
NO137754C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive steroidforbindelser
NO138251C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzylaminer
NO140299C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-5-aminoalkyl-4-oksazolin-2-oner
NO136841C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive fenylimidazolidinoner
NO137696C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzodiazepin-derivater
NO137695C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-tienylmetyl-heterocykliske forbindelser
NO136977C (no) Analogifremgangsm}te for mstilling av terapeutisk aktive oksazolidiner